Evidence map›Paper›PMID 34936681›Full record

ArticlePloS one2021

Mortality predictors of hospitalized patients with COVID-19: Retrospective cohort study from Nur-Sultan, Kazakhstan.

Yuriy Pya, Makhabbat Bekbossynova, Abduzhappar Gaipov, Timur Lesbekov, Timur Kapyshev, Aidyn Kuanyshbek, Ainur Tauekelova, Liya Litvinova, Aliya Sailybayeva, Ivan Vakhrushev and 1 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
0.7field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it, 14 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Yuriy PyaDepartment of Cardiac Surgery, National Research Cardiac Surgery Center, Nur-Sultan, Kazakhstan.
Makhabbat BekbossynovaDepartment of Cardiology, National Research Cardiac Surgery Center, Nur-Sultan, Kazakhstan.
Abduzhappar GaipovDepartment of Medicine, School of Medicine, Nazarbayev University, Nur-Sultan, Kazakhstan.
Timur LesbekovDepartment of Cardiac Surgery, National Research Cardiac Surgery Center, Nur-Sultan, Kazakhstan.
Timur KapyshevCenter of Excellence, National Research Cardiac Surgery Center, Nur-Sultan, Kazakhstan.
Aidyn KuanyshbekDepartment of Anesthesiology, Reanimation and Intensive Care Unit, National Research Cardiac Surgery Center, Nur-Sultan, Kazakhstan.
Ainur TauekelovaDepartment of Cardiology, National Research Cardiac Surgery Center, Nur-Sultan, Kazakhstan.
Liya LitvinovaQuality and Risk Management Department, National Research Cardiac Surgery Center, Nur-Sultan, Kazakhstan.
Aliya SailybayevaResearch Department, National Research Cardiac Surgery Center, Nur-Sultan, Kazakhstan.ORCID 0000-0002-1489-3837
Ivan VakhrushevDepartment of Anesthesiology, Reanimation and Intensive Care Unit, National Research Cardiac Surgery Center, Nur-Sultan, Kazakhstan.
Antonio Sarria-SantameraDepartment of Medicine, School of Medicine, Nazarbayev University, Nur-Sultan, Kazakhstan.
Nazarbayev University · KZNational Research Center for Maternal and Child Health · KZ

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundFirst reported case of Severe acute respiratory syndrome-related coronavirus 2 (SARS-CoV-2) in Kazakhstan was identified in March 2020. Many specialized tertiary hospitals in Kazakhstan including National Research Cardiac Surgery Center (NRCSC) were re-organized to accept coronavirus disease 2019 (COVID-19) infected patients during summer months of 2020. Although many studies from worldwide reported their experience in treating patients with COVID-19, there are limited data available from the Central Asia countries. The aim of this study is to identify predictors of mortality associated with COVID-19 in NRCSC tertiary hospital in Nur-Sultan, Kazakhstan.

methodsThis is a retrospective cohort study of patients admitted to the NRCSC between June 1st-August 31st 2020 with COVID-19. Demographic, clinical and laboratory data were collected from electronic records. In-hospital mortality was assessed as an outcome. Patients were followed-up until in-hospital death or discharge from the hospital. Descriptive statistics and factors associated with mortality were assessed using univariate and multivariate logistic regression models.

resultsTwo hundred thirty-nine admissions were recorded during the follow-up period. Mean age was 57 years and 61% were males. Median duration of stay at the hospital was 8 days and 34 (14%) patients died during the hospitalization. Non-survivors were more likely to be admitted later from the disease onset, with higher fever, lower oxygen saturation and increased respiratory rate compared to survivors. Leukocytosis, lymphopenia, anemia, elevated liver and kidney function tests, hypoproteinemia, elevated inflammatory markers (C-reactive protein (CRP), ferritin, and lactate dehydrogenase (LDH)) and coagulation tests (fibrinogen, D-dimer, international normalized ratio (INR), and activated partial thromboplastin time (aPTT)) at admission were associated with mortality. Age (OR 1.2, CI:1.01-1.43), respiratory rate (OR 1.38, CI: 1.07-1.77), and CRP (OR 1.39, CI: 1.04-1.87) were determined to be independent predictors of mortality.

conclusionThis study describes 14% mortality rate from COVID-19 in the tertiary hospital. Many abnormal clinical and laboratory variables at admission were associated with poor outcome. Age, respiratory rate and CRP were found to be independent predictors of mortality. Our finding would help healthcare providers to predict the risk factors associated with high risk of mortality. Further investigations involving large cohorts should be provided to support our findings.

Indexed as

AdultAgedAge FactorsBiomarkersCohort StudiesCOVID-19FemaleHospitalizationHospital MortalityHumansKazakhstanMaleMiddle AgedPrognosisRespiratory RateRetrospective StudiesBiomarkers

Identifiers

PMID34936681
PMCPMC8694457
OpenAlexW4200053053

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.